Stock CARDIUM THERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Insiders Cardium Therapeutics Inc Nyse

Equities

US1419161062

End-of-day quote Nyse
Other stock markets
- USD - Intraday chart for Cardium Therapeutics Inc
2022 Gene Biotherapeutics, Inc. Auditor Raises 'Going Concern' Doubt CI
2021 Gene Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Gene Biotherapeutics, Inc. Announces Resignation of Murray H. Hutchison from the Board
CI
Gene Biotherapeutics, Inc. Announces Management Changes
CI
Gene Biotherapeutics, Inc. Appoints James L. Grainer as Chief Financial Officer
CI
Gene Biotherapeutics Inc. Announces Retirement of Gerald J. Lewis from its Board of Directors
CI
Taxus Cardium Pharmaceuticals Group, Inc. Announces Board Retirements
CI
Dennis Mulroy Resigns as Chief Financial Officer of Taxus Cardium Pharmaceuticals Group Inc on April 3, 2015
CI
TaxuCardium Pharmaceuticals Group Inc. Announces Election of New Directors
CI
Cardium Therapeutics, Inc. has Changed its Name to Taxus Cardium Pharmaceuticals Group Inc
CI
Cardium Therapeutics Inc. Announces Medical Advisory Board to Support Excellagen Advanced Wound Care Product
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CRXM Stock
  4. Stock
  5. News Cardium Therapeutics Inc
  6. Insiders